About
Ampersand Health is a remote patient monitoring and behavioural therapeutics company focused on chronic inflammatory diseases such as IBD, Arthritis and Psoriasis. Our platform and pathways help HCPs monitor and manage complex patient groups in an out-of-hospital setting and our apps use CBT, ACT and behavioural science to help patients develop the knowledge and confidence to self-manage effectively. We also work with HCPs and our pharma partners to support faster diagnosis, better escalation and more equitable access to treatment.
The platform is CE marked, ISO 13485 compliant and regulated as a class 1 medical device by the MHRA. It is used at over 30 hospitals in a routine care or a research context, with a particular focus on supporting gastroenterology, rheumatology and dermatology practices.
Key Facts
9 studies, 47% reduction in face to face appointments, 89% reduction in A&E visits, 23% improvement in anxiety and depression, 34% improvement in quality of life. 35,000 patients, 30+ hospital deployments, 3 pharma partnerships, 3 charity partnerships.
Successes in UK/NHS
Our platform supports out of hospital care (PIFU) at over 30 hospitals. We also work with three global pharmaceutical companies in a Joint Working context, supporting their key accounts to address issues around capacity, diagnosis and escalation for treatment. We are included in the NHSX playbooks and have been case studied by NICE and the CQC.Company details
Solutions
Delivering advanced patient care
Enabling self-care
Specialism
Long-term condition monitoring
Specialised self-care (except mental health)
Company details
Want to connect with this innovator?
Make an enquiryWebsite
www.ampersandhealth.co.ukMarkets already exporting to
We have patients in 193 countries and upcoming hospital deployments in Ireland and Canada. But at present all our hospital sites are in the UK..
Desired Markets
Germany, Switzerland and Austria Nordics France Canada US (in future)
Desired customer types
health systems, hospitals and pharmaceutical companies